Research/art/teacher profile of a person
Name and surname:
doc. MUDr. Richard Imrich, DrSc.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Imrich
I.2 - Name
Richard
I.3 - Degrees
doc. MUDr. DrSc.
I.4 - Year of birth
1974
I.5 - Name of the workplace
Institute of Physiology, Faculty of Medicine
I.6 - Address of the workplace
Sasinkova 4, Bratislava
I.7 - Position
university teacher - associated professor
I.8 - E-mail address
imrich6@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/22248
I.10 - Name of the study field in which a person works at the university
Normal and pathological physiology
I.11 - ORCID iD
0000-0002-1747-7150

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University Bratislava
II.b - Year
1998
II.c - Study field and programme
General medicine
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University Bratislava
II.b - Year
2001
II.c - Study field and programme
General medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Slovak Academy of Sciences
II.b - Year
2003
II.c - Study field and programme
Normal and pathological physiology
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of Medicine, Comenius University Bratislava
II.b - Year
2017
II.c - Study field and programme
Normal and pathological physiology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)
II.a - Name of the university or institution
Slovak Academy of Sciences
II.b - Year
2014
II.c - Study field and programme
Normal and pathological physiology

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
researcher Institute of Experimental Endocrinology, now Biomedical Research Center 2001-continues
center coordinator, general director (2017-2022) National Institute of Rheumatic Diseases 2012-2023
university teacher - associated professor Faculty of Medicine, Comenius University Bratislava 2014-2017
university teacher - associated professor Faculty of Medicine, Slovak Medical University Bratislava 2019-2023
university teacher - associated professor Faculty of Medicine, Comenius University Bratislava 2023-continues

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Physiology General medicine I. General medicine
Physiology Dentistry I. Dentistry
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
2
V.4.c - Dissertation (third degree)
1
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
126
VI.1.b - Over the last six years
27
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
126
VI.1.b - Over the last six years
27
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
2508
VI.1.b - Over the last six years
1095
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
2508
VI.1.b - Over the last six years
1095
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
10
VI.1.b - Over the last six years
4
VI.2 - The most significant research/artistic/other outputs
1

Ranganath LR, Psarelli EE, Arnoux JB, Braconi D, Briggs M, Bröijersén A, Loftus N, Bygott H, Cox TF, Davison AS, Dillon JP, Fisher M, FitzGerald R, Genovese F, Glasova H, Hall AK, Hughes AT, Hughes JH, Imrich R, Jarvis JC, Khedr M, Laan D, Le Quan Sang KH, Luangrath E, Lukáčová O, Milan AM, Mistry A, Mlynáriková V, Norman BP, Olsson B, Rhodes NP, Rovenský J, Rudebeck M, Santucci A, Shweihdi E, Scott C, Sedláková J, Sireau N, Stančík R, Szamosi J, Taylor S, van Kan C, Vinjamuri S, Vrtíková E, Webb C, West E, Záňová E, Zatkova A, Gallagher JA.Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2020 Sep;8(9):762-772.

2

Ranganath LR, Milan AM, Hughes AT, Davison AS, M K, Norman BP, Bou-Gharios G, Gallagher JA, Imrich R, Arnoux JB, Rudebeck M, Olsson B. Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria. Sci Rep. 2022 Sep 27;12(1):16083

3

Imrich R, Sedláková J, Úlehlová M, Gornall M, Jackson R, Olsson B, Rudebeck M, Gallagher J, Lukáčová O, Mlynáriková V, Stančík R, Vrtíková E, Záňová E, Zaťková A, Arnoux JB, Rovenský J, Luangrath E, Bygott H, Khedr M, Ranganath LR.Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone. RMD Open. 2022 Oct;8(2):e002422.

4

Cant HEO, Chatzidaki I, Olsson B, Rudebeck M, Arnoux JB, Imrich R, Eddowes LA, Ranganath LR. Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index. JIMD Rep. 2022 May 10;63(4):361-370.

5

Olsson B, Ranganath L, Arnoux JB, Imrich R, Milan A, Rudebeck M. Effects of a protein-restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria. JIMD Rep. 2021 Nov 9;63(1):41-49.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Ranganath LR, Psarelli EE, Arnoux JB, Braconi D, Briggs M, Bröijersén A, Loftus N, Bygott H, Cox TF, Davison AS, Dillon JP, Fisher M, FitzGerald R, Genovese F, Glasova H, Hall AK, Hughes AT, Hughes JH, Imrich R, Jarvis JC, Khedr M, Laan D, Le Quan Sang KH, Luangrath E, Lukáčová O, Milan AM, Mistry A, Mlynáriková V, Norman BP, Olsson B, Rhodes NP, Rovenský J, Rudebeck M, Santucci A, Shweihdi E, Scott C, Sedláková J, Sireau N, Stančík R, Szamosi J, Taylor S, van Kan C, Vinjamuri S, Vrtíková E, Webb C, West E, Záňová E, Zatkova A, Gallagher JA.Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2020 Sep;8(9):762-772.

2

Ranganath LR, Milan AM, Hughes AT, Davison AS, M K, Norman BP, Bou-Gharios G, Gallagher JA, Imrich R, Arnoux JB, Rudebeck M, Olsson B. Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria. Sci Rep. 2022 Sep 27;12(1):16083

3

Imrich R, Sedláková J, Úlehlová M, Gornall M, Jackson R, Olsson B, Rudebeck M, Gallagher J, Lukáčová O, Mlynáriková V, Stančík R, Vrtíková E, Záňová E, Zaťková A, Arnoux JB, Rovenský J, Luangrath E, Bygott H, Khedr M, Ranganath LR.Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone. RMD Open. 2022 Oct;8(2):e002422.

4

Cant HEO, Chatzidaki I, Olsson B, Rudebeck M, Arnoux JB, Imrich R, Eddowes LA, Ranganath LR. Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index. JIMD Rep. 2022 May 10;63(4):361-370.

5

Olsson B, Ranganath L, Arnoux JB, Imrich R, Milan A, Rudebeck M. Effects of a protein-restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria. JIMD Rep. 2021 Nov 9;63(1):41-49.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, Srbecky M, Imrich R, Kyselovicova O, Belan V, Jelok I, Wolfrum C, Klimes I, Krssak M, Zemkova E, Gasperikova D, Ukropec J, Ukropcova B.Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol. 2014 Mar 1;592(5):1091-107. 311 citácií

2

Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E, Klimes I.Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes. 2006 May;114(5):249-56. 131 citácií

3

Goldstein DS, Holmes C, Bentho O, Sato T, Moak J, Sharabi Y, Imrich R, Conant S, Eldadah BA. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord. 2008 Dec;14(8):600-7. 137 citácií

4

Ranganath LR, Milan AM, Hughes AT, Dutton JJ, Fitzgerald R, Briggs MC, Bygott H, Psarelli EE, Cox TF, Gallagher JA, Jarvis JC, van Kan C, Hall AK, Laan D, Olsson B, Szamosi J, Rudebeck M, Kullenberg T, Cronlund A, Svensson L, Junestrand C, Ayoob H, Timmis OG, Sireau N, Le Quan Sang KH, Genovese F, Braconi D, Santucci A, Nemethova M, Zatkova A, McCaffrey J, Christensen P, Ross G, Imrich R, Rovensky J. Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis. 2016 Feb;75(2):362-7. 107 citácií

5

Bertok T, Klukova L, Sediva A, Kasák P, Semak V, Micusik M, Omastova M, Chovanová L, Vlček M, Imrich R, Vikartovska A, Tkac J.Ultrasensitive impedimetric lectin biosensors with efficient antifouling properties applied in glycoprofiling of human serum samples. Anal Chem. 2013 Aug 6;85(15):7324-32. 80 citácií

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

FP7-HEALTH-2013-INNOVATION-1 Clinical Development of Nitisinone for Alkaptonuria (DevelopAKUre) 2012-2019, EudraCT 2012-005340-24, EudraCT 2013-001633-41, koordinátor centra

2

APVV-15-0228 Sclerosis multiplex - Úloha mitochondriálnej dysfunkcie v inzulinovej rezistencii, Multiple sclerosis - The role of mitochondrial dysfunction in insulin resistance. ClinicalTrials.gov Identifier: NCT03052595, zodpovedný riešiteľ, 2015-2019

3

MZ-2018/37-LFUK-11 The use of GLP-1 analogs in the multiple sclerosis treatment (MSGLP) 2018-2021, ClinicalTrials.gov Identifier: NCT01444833, spoluriešiteľ

4

APVV-21-0261 Účinky GLP-1 analógu na sclerosis multiplex, Effects of GLP-1 Analog on Multiple Sclerosis (GAMS) 2022-2026

5

ERA4Health, Fostering a European Research Area for Health Research (HORIZON-HLTH-2022-DISEASE-03), INSTITUTO DE SALUD CARLOS III (ISCIII), Spain, 2022-2029, Role: Co-investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Free University of Brussels Brusel, Belgicko 01/2004-05/2004 Grant EULAR
National Institutes of Health Bethesda, MD, USA 01/2005-01/2008 NIH visiting fellow
National Institutes of Health Bethesda, MD, USA 01/2008-01/2015 NIH Guest Researchers

IX. - Other relevant facts

Date of last update
2024-05-02